1 / 3

3 rd Workshop on Metronomic Anti- Angiogenic Chemotherapy: From Bench to Bedside

hammer
Télécharger la présentation

3 rd Workshop on Metronomic Anti- Angiogenic Chemotherapy: From Bench to Bedside

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Metronomic chemotherapy – the use of relatively non-toxic lower doses of conventional chemotherapy drugs administered at close, regular intervals without any prolonged break periods – is attracting increasing interest as a supplement or alternative to conventional chemotherapy regimens. Currently there are at least five randomized phase III clinical trials underway around the world evaluating the treatment concept. A number of these trials as well as many phase II trials involve combination with targeted biologic agents, especially antiangiogenic drugs. The purpose of this workshop is to bring together a small group of dedicated clinical and basic research investigators to discuss the latest clinical and preclinical developments in the field with the goal of utilizing metronomic chemotherapy more effectively in both pediatric and adult oncology patients. 3rd Workshop onMetronomic Anti-Angiogenic Chemotherapy:From Bench to Bedside Program Haifa, Israel 22-23 March 2012

  2. 3rd Workshop onMetronomic Anti-Angiogenic Chemotherapy Faculty Robert S. Kerbel, Toronto-Canada Abraham Kuten, Haifa-Israel Myriam Ben-Arush, Haifa-Israel Yuval Shaked, Haifa-Israel Mark Kieran, Boston-USA Francesco Bertolini, Milan- Italy Barton Kamen, New Jersey-USA Eddy Pasquier, Sydney-Australia Nicolas Andre, Marseille-France JaroslavSterba, Brno- Czech Republic ShripadBanavali, Mumbai-India

  3. 3rd Workshop onMetronomic Anti-Angiogenic Chemotherapy Scientific Contact and Abstract Submission Yuval Shaked yshaked@tx.technion.ac.il General Organization MerkazAzrieli 3, floor 29 Tel Aviv 67021, Israel Tel: +972-3-6081520 Fax: +972-3-6081522 Email: knasim@imknasim.co.il

More Related